Prestige Brand Holdings Inc (PBH)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE
Market Cap: $2.19B
Last updated: Nov 17, 2026 at 11:06 AM ET
Prestige Brand Holdings Inc (PBH) Stock Forecast
Analysts expect Prestige Brand Holdings (PBH) to earn $4.50 per share in the fiscal year ending Mar 31, 2027, on revenue of $1.28B. Of 7 analysts, 5 rate the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Mar 31, 2027 was revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 2.14, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 71% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 14.3% |
| Buy | 4 | 57.1% |
| Hold | 2 | 28.6% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 13.1% and revenue estimates rise 7.0%.
- Fiscal year ending Mar 31, 2027
- $4.50
- EPS consensus, revenue $1.28B
- Fiscal year ending Mar 31, 2028
- $5.09
- EPS consensus, revenue $1.37B
- Next report
- Feb 3, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Mar 31, 2027 | $4.50 | $4.48 to $4.52 | 7 | $1.28B | $1.28B to $1.29B | 7 |
| Mar 31, 2028 | $5.09 | $4.80 to $5.23 | 8 | $1.37B | $1.35B to $1.40B | 8 |
Quarterly Estimates
The EPS consensus rises from $1.05 for the quarter ending Dec 31, 2026 to $1.35 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.05 | $1.05 to $1.06 | 6 | $328.02M | $327.53M to $328.30M | 6 |
| Mar 31, 2027 | $1.35 | $1.29 to $1.44 | 8 | $354.88M | $341.15M to $374.12M | 8 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 3 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Mar 31, 2027 | 1 | 1 |
| Quarter ending Dec 31, 2026 | 0 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Mar 31, 2027 has fallen 1.5% from $4.57.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Mar 31, 2027 | $4.50 | $4.58 | $4.57 | $4.57 | $4.57 | -1.5% |
| Fiscal year ending Mar 31, 2028 | $5.09 | $5.11 | $5.08 | $5.08 | $5.08 | +0.1% |
| Quarter ending Dec 31, 2026 | $1.05 | $1.23 | $1.24 | $1.24 | $1.24 | -15.1% |
Frequently Asked Questions About PBH
What is the PBH stock forecast?
Consensus analyst estimates put Prestige Brand Holdings's EPS at $4.50 for the fiscal year ending Mar 31, 2027, on revenue of $1.28B. The consensus rating from 7 analysts is Buy.
How do analysts rate PBH stock?
Of 7 analysts covering Prestige Brand Holdings, 1 rates it Strong Buy, 4 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from PBH next year?
For the fiscal year ending Mar 31, 2027, the consensus EPS estimate is $4.50, with estimates from $4.48 to $4.52 from 7 analysts. For the fiscal year ending Mar 31, 2028, the consensus EPS estimate is $5.09, with estimates from $4.80 to $5.23 from 8 analysts.
What revenue do analysts expect from Prestige Brand Holdings next year?
For the fiscal year ending Mar 31, 2027, the consensus revenue estimate is $1.28B, with estimates from $1.28B to $1.29B. For the fiscal year ending Mar 31, 2028, the consensus revenue estimate is $1.37B, with estimates from $1.35B to $1.40B.
How many analysts cover PBH?
7 analysts rate Prestige Brand Holdings stock, and 7 analysts estimate its EPS for the fiscal year ending Mar 31, 2027.
PBH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors